BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21442308)

  • 21. Shared and individual specificities of immunodominant cytotoxic T-cell clones in paroxysmal nocturnal hemoglobinuria as determined by molecular analysis.
    Plasilova M; Risitano AM; O'Keefe CL; Rodriguez A; Wlodarski M; Young NS; Maciejewski J
    Exp Hematol; 2004 Mar; 32(3):261-9. PubMed ID: 15003311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria.
    Pramoonjago P; Pakdeesuwan K; Siripanyaphinyo U; Chinprasertsuk S; Kinoshita T; Wanachiwanawin W
    Br J Haematol; 1999 May; 105(2):497-504. PubMed ID: 10233427
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paroxysmal nocturnal hemoglobinuria: current issues in pathophysiology and treatment.
    Young NS
    Curr Hematol Rep; 2005 Mar; 4(2):103-9. PubMed ID: 15720958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathophysiology of paroxysmal nocturnal hemoglobinuria.
    Parker CJ
    Exp Hematol; 2007 Apr; 35(4):523-33. PubMed ID: 17379062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Paroxysmal nocturnal hemoglobinuria].
    Wada H; Kanamaru A
    Nihon Rinsho; 1996 Sep; 54(9):2507-12. PubMed ID: 8890586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of paroxysmal nocturnal hemoglobinuria (PNH)].
    Chrobák L; Dulícek P; Zák P
    Vnitr Lek; 2001 Dec; 47(12):880-6. PubMed ID: 11826554
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical paroxysmal nocturnal hemoglobinuria is the result of expansion of glycosyl-phosphatidyl-inositol-anchored protein-deficient clone in the condition of deficient hematopoiesis.
    Pakdeesuwan K; Muangsup W; Pratya YU; Issaragrisil S; Wanachiwanawin W
    Int J Hematol; 2001 Jan; 73(1):64-70. PubMed ID: 11372757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
    Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
    Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The clinical significance of evolution of paroxysmal nocturnal haemoglobinuria clones in aplastic anemia patients].
    Li YM; Li XX; Ge ML; Shi J; Shao YQ; Qian LS; Zheng YZ
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):117-22. PubMed ID: 22730662
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pathogenetic link between aplastic anemia and paroxysmal nocturnal hemoglobinuria is suggested by a high frequency of aplastic anemia patients with a deficiency of phosphatidylinositol glycan anchored proteins.
    Schrezenmeier H; Hertenstein B; Wagner B; Raghavachar A; Heimpel H
    Exp Hematol; 1995 Jan; 23(1):81-7. PubMed ID: 7995374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA Dr-Dq haplotypes and the TNFA-308 polymorphism: associations with asthma and allergy.
    Munthe-Kaas MC; Carlsen KL; Carlsen KH; Egeland T; Håland G; Devulapalli CS; Akselsen H; Undlien D
    Allergy; 2007 Sep; 62(9):991-8. PubMed ID: 17686102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deficiency of glycosyl phosphatidylinositol-anchored proteins in polymorphonuclear leukocytes from patients with paroxysmal nocturnal hemoglobinuria with low-grade hemolysis.
    Shibuya K; Ninomiya H; Muraki Y; Nagasawa T; Abe T
    Int J Hematol; 1993 Aug; 58(1-2):15-20. PubMed ID: 7693026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Evaluation and quantification of complement-sensitive red cells in PNH and aplastic anemia-PNH syndrome].
    Shichishima T; Terasawa T; Uchida T; Kariyone S
    Rinsho Ketsueki; 1989 Mar; 30(3):297-302. PubMed ID: 2769953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The novel monoclonal antibody By114 helps detect the early emergence of a paroxysmal nocturnal hemoglobinuria clone in aplastic anemia.
    Tooze JA; Saso R; Marsh JC; Papadopoulos A; Pulford K; Gordon-Smith EC
    Exp Hematol; 1995 Dec; 23(14):1484-91. PubMed ID: 8542935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paroxysmal nocturnal hemoglobinuria with copy number-neutral 6pLOH in GPI (+) but not in GPI (-) granulocytes.
    Ueda Y; Nishimura J; Murakami Y; Kajigaya S; Kinoshita T; Kanakura Y; Young NS
    Eur J Haematol; 2014; 92(5):450-3. PubMed ID: 24931618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paroxysmal nocturnal hemoglobinuria (membrane defect, pathogenesis, aplastic anemia, diagnosis).
    Chrobák L
    Acta Medica (Hradec Kralove); 2000; 43(1):3-8. PubMed ID: 10934778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Tiu R; Maciejewski J
    Int J Hematol; 2006 Aug; 84(2):113-7. PubMed ID: 16926131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
    Kinoshita T; Inoue N
    Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular genetics of paroxysmal nocturnal hemoglobinuria.
    Inoue N; Murakami Y; Kinoshita T
    Int J Hematol; 2003 Feb; 77(2):107-12. PubMed ID: 12627844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.